tradingkey.logo
tradingkey.logo
Search

Genenta Science SPA

GNTA
Add to Watchlist
1.300USD
0.0000.00%
Close 08-14 16:00ETQuotes delayed by 15 min
30.67MMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Thu, May 7
Updated: Thu, May 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Paracchi (Pierluigi)
9.76%
IRCCS Ospedale San Raffaele
8.04%
Naldini (Luigi M.D., Ph.D.)
5.88%
Roveda (Gaudenzio)
4.14%
Fidim S.r.l.
3.81%
Other
68.37%
Shareholders
Shareholders
Proportion
Paracchi (Pierluigi)
9.76%
IRCCS Ospedale San Raffaele
8.04%
Naldini (Luigi M.D., Ph.D.)
5.88%
Roveda (Gaudenzio)
4.14%
Fidim S.r.l.
3.81%
Other
68.37%
Shareholder Types
Shareholders
Proportion
Individual Investor
25.70%
Corporation
16.04%
Hedge Fund
6.87%
Investment Advisor
5.10%
Holding Company
2.86%
Investment Advisor/Hedge Fund
1.02%
Sovereign Wealth Fund
0.96%
Research Firm
0.19%
Bank and Trust
0.01%
Other
41.25%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
24
3.34M
14.15%
+1.02M
2025Q4
19
1.83M
9.54%
-414.06K
2025Q3
16
1.96M
10.22%
-334.32K
2025Q2
24
9.06M
49.52%
-260.05K
2025Q1
28
9.12M
49.85%
-26.40K
2024Q4
28
8.70M
47.57%
-293.74K
2024Q3
26
8.60M
47.05%
-368.88K
2024Q2
26
8.48M
46.40%
-155.29K
2024Q1
25
8.51M
46.63%
+417.20K
2023Q4
25
8.38M
45.98%
+434.51K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Paracchi (Pierluigi)
2.30M
9.83%
+6.39K
+0.28%
Jan 25, 2026
IRCCS Ospedale San Raffaele
1.90M
8.09%
--
--
Mar 26, 2025
Naldini (Luigi M.D., Ph.D.)
1.39M
5.92%
--
--
Mar 26, 2025
Gentner (Bernard)
692.87K
2.96%
--
--
Mar 26, 2025
Citadel Advisors LLC
655.16K
2.8%
+642.68K
+5147.19%
Dec 31, 2025
Russo (Carlo)
602.42K
2.57%
+4.00K
+0.67%
Mar 26, 2025
View more
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.